Litcius/Paper detail

Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Anna Gaimari, Michele Fusaroli, Emanuel Raschi, Elisa Baldin, Luca Vignatelli, Francesco Nonino, Fabrizio De Ponti, Jessica Mandrioli, Elisabetta Poluzzi

2022Drug Safety17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAmyotrophic lateral sclerosisAdverse Event Reporting SystemAdverse effectUstekinumabOdds ratioInternal medicineOncologyDiseaseInfliximabAmyotrophic Lateral Sclerosis ResearchPeripheral Neuropathies and DisordersSpondyloarthritis Studies and Treatments
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System | Litcius